S Lehmann
Overview
Explore the profile of S Lehmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
3036
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schraen-Maschke S, Duhamel A, Vidal J, Ramdane N, Vaudran L, Dussart C, et al.
Neurobiol Dis
. 2024 Feb;
193:106459.
PMID: 38423192
Background And Purpose: Blood-based biomarkers are a non-invasive solution to predict the risk of conversion of mild cognitive impairment (MCI) to dementia. The utility of free plasma amyloid peptides (not...
2.
Ungerer J, Pally A, Kononov A, Lehmann S, Ridderbos J, Potts P, et al.
Nat Commun
. 2024 Feb;
15(1):1068.
PMID: 38316779
Combining superconducting resonators and quantum dots has triggered tremendous progress in quantum information, however, attempts at coupling a resonator to even charge parity spin qubits have resulted only in weak...
3.
Clua Provost C, Auboyer L, Rovelet-Lecrux A, Monzo C, Schob E, Andreux F, et al.
Stem Cell Res
. 2023 Nov;
73:103250.
PMID: 37979430
Induced Pluripotent Stem Cell (iPSC) lines derived from healthy individuals are helpful and essential tools for disease modelling. Here, we described the reprogramming of skin fibroblasts obtained from a healthy...
4.
Clua Provost C, Auboyer L, Rovelet-Lecrux A, Monzo C, Schob E, Lehmann S, et al.
Stem Cell Res
. 2023 Oct;
72:103216.
PMID: 37783001
Alzheimer's disease (AD) is a progressive neurological disorder and the most common form of dementia worldwide. Sporadic Alzheimer's disease (sAD) cases are the main forms, over 95% of AD cases,...
5.
Delaby C, Hirtz C, Lehmann S
Rev Neurol (Paris)
. 2022 Nov;
179(3):161-172.
PMID: 36371265
The increasing number of people with advanced Alzheimer's disease (AD) represents a significant psychological and financial cost to the world population. Accurate detection of the earliest phase of preclinical AD...
6.
Delaby C, Lehmann S
J Neural Transm (Vienna)
. 2022 Feb;
129(2):131.
PMID: 35175386
No abstract available.
7.
Delaby C, Lehmann S
J Neural Transm (Vienna)
. 2022 Jan;
129(2):129-130.
PMID: 35076778
No abstract available.
8.
Gluschke J, Seidl J, Lyttleton R, Nguyen K, Lagier M, Meyer F, et al.
Mater Horiz
. 2021 Nov;
8(1):224-233.
PMID: 34821301
A central endeavour in bioelectronics is the development of logic elements to transduce and process ionic to electronic signals. Motivated by this challenge, we report fully monolithic, nanoscale logic elements...
9.
Barrat A, Cattuto C, Kivela M, Lehmann S, Saramaki J
J R Soc Interface
. 2021 May;
18(178):20201000.
PMID: 33947224
Non-pharmaceutical interventions are crucial to mitigate the COVID-19 pandemic and contain re-emergence phenomena. Targeted measures such as case isolation and contact tracing can alleviate the societal cost of lock-downs by...
10.
Cencetti G, Santin G, Longa A, Pigani E, Barrat A, Cattuto C, et al.
Nat Commun
. 2021 Mar;
12(1):1655.
PMID: 33712583
Digital contact tracing is a relevant tool to control infectious disease outbreaks, including the COVID-19 epidemic. Early work evaluating digital contact tracing omitted important features and heterogeneities of real-world contact...